Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Memantine"" wg kryterium: Temat


Tytuł:
In Vitro Permeability Study of Homotaurine Using a High-Performance Liquid Chromatography with Fluorescence Detection Pre-Column Derivatization Method.
Autorzy:
Ntorkou M; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Tsanaktsidou E; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Chachlioutaki K; Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Fatouros DG; Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Markopoulou CK; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Oct 14; Vol. 28 (20). Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article
MeSH Terms:
Acetylcysteine*/chemistry
Memantine*
Chromatography, High Pressure Liquid/methods ; o-Phthalaldehyde/chemistry ; Indicators and Reagents ; Tiopronin ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.
Autorzy:
Kondak C; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.; Institute of Pharmacology and Clinical Pharmacy, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
Leith M; Department of Chemistry, School of Natural and Computing Sciences, University of Aberdeen, Aberdeen AB24 3UE, UK.
Baddeley TC; Department of Chemistry, School of Natural and Computing Sciences, University of Aberdeen, Aberdeen AB24 3UE, UK.; TauRx Therapeutics Ltd., Aberdeen AB24 5RP, UK.
Santos RX; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Harrington CR; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.; TauRx Therapeutics Ltd., Aberdeen AB24 5RP, UK.
Wischik CM; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.; TauRx Therapeutics Ltd., Aberdeen AB24 5RP, UK.
Riedel G; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Klein J; Institute of Pharmacology and Clinical Pharmacy, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 28; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Memantine*/pharmacology
Memantine*/therapeutic use
Alzheimer Disease*/drug therapy
Alzheimer Disease*/genetics
Alzheimer Disease*/chemically induced
Mice ; Animals ; Rivastigmine/pharmacology ; tau Proteins/genetics ; tau Proteins/metabolism ; Mice, Transgenic ; Cholinesterase Inhibitors/pharmacology ; Mitochondria/metabolism
Czasopismo naukowe
Tytuł:
Effects of memantine on mania-like phenotypes exhibited by Drosophila Shaker mutants.
Autorzy:
Mocci I; Institute of Translational Pharmacology, National Research Council, Science and Technology Park of Sardinia, Cagliari, Italy.
Casu MA; Institute of Translational Pharmacology, National Research Council, Science and Technology Park of Sardinia, Cagliari, Italy.
Sogos V; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Liscia A; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Angius R; Unit of Biomedical Research Support, NMR Laboratory and Bioanalytical Technologies, Sardegna Ricerche, Science and Technology Park of Sardinia, Cagliari, Italy.
Cadeddu F; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Fanti M; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Muroni P; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Talani G; Institute of Neuroscience, National Research Council, Monserrato, Italy.
Diana A; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Collu M; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Setzu MD; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Jul; Vol. 29 (7), pp. 1750-1761. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Memantine*/pharmacology
Mania*
Animals ; Humans ; Receptors, N-Methyl-D-Aspartate/genetics ; Receptors, N-Methyl-D-Aspartate/metabolism ; Drosophila/metabolism ; Drosophila melanogaster/metabolism ; Glutamic Acid/metabolism ; Phenotype
Czasopismo naukowe
Tytuł:
The Highs and Lows of Memantine-An Autophagy and Mitophagy Inducing Agent That Protects Mitochondria.
Autorzy:
de Wet S; Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.
Mangali A; Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.
Batt R; Department of Electric and Electronic Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.
Kriel J; Microscopy Unit, Central Analytical Facility, Stellenbosch University, Stellenbosch 7600, South Africa.
Vahrmeijer N; Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.
Niehaus D; Department of Psychiatry and Stikland Hospital, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7530, South Africa.
Theart R; Department of Electric and Electronic Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.
Loos B; Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Jun 27; Vol. 12 (13). Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mitophagy*
Memantine*/pharmacology
Mice ; Animals ; Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology ; Autophagy ; Mitochondria/metabolism
Czasopismo naukowe
Tytuł:
Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma.
Autorzy:
Büttner T; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. .; Clinic for Urology and Paediatric Urology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany. .
Maerevoet MKE; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Giordano FA; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Veldwijk MR; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Herskind C; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Ruder AM; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Jan 30; Vol. 19 (1), pp. 16. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/radiotherapy
Glioblastoma*/metabolism
Radiation-Sensitizing Agents*/pharmacology
Humans ; Xenon/pharmacology ; Xenon/metabolism ; Excitatory Amino Acid Antagonists/pharmacology ; Memantine ; HeLa Cells ; Receptors, N-Methyl-D-Aspartate
Czasopismo naukowe
Tytuł:
Chondroitin sulfate proteoglycan is a potential target of memantine to improve cognitive function via the promotion of adult neurogenesis.
Autorzy:
Maeda S; Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamada J; Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Iinuma KM; Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nadanaka S; Department of Biochemistry, Kobe Pharmaceutical University, Kobe, Japan.
Kitagawa H; Department of Biochemistry, Kobe Pharmaceutical University, Kobe, Japan.
Jinno S; Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2022 Oct; Vol. 179 (20), pp. 4857-4877. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chondroitin Sulfate Proteoglycans*/metabolism
Chondroitin Sulfate Proteoglycans*/pharmacology
Memantine*/pharmacology
Animals ; Cognition ; Mice ; Nerve Growth Factors/pharmacology ; Neurogenesis
Czasopismo naukowe
Tytuł:
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta-analysis.
Autorzy:
Elnaiem W; Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Benmelouka AY; Faculty of Medicine, University of Algiers, Algiers, Algeria.
Elgendy AMN; Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Abdelgalil MS; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Brimo Alsaman MZ; Faculty of Medicine, University of Aleppo, Aleppo, Syria.
Mogheeth A; Faculty of Medicine, Alazhar University, Assiut, Egypt.; Urosurgical Resident Doctor, Alazhar University Hospital, Assiut, Egypt.
Ali MM; Faculty of Pharmacy, Alazhar University, Assiut, Egypt.
Yousof SM; Physiology Department, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.; Physiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Pokaż więcej
Źródło:
Human psychopharmacology [Hum Psychopharmacol] 2022 Sep; Vol. 37 (5), pp. e2841. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Autism Spectrum Disorder*/drug therapy
Memantine*/adverse effects
Anxiety Disorders/drug therapy ; Child ; Excitatory Amino Acid Antagonists/adverse effects ; Humans ; Risperidone/therapeutic use
Czasopismo naukowe
Tytuł:
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits.
Autorzy:
Bellingacci L; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Canonichesi J; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Sciaccaluga M; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Megaro A; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Mazzocchetti P; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Di Mauro M; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Costa C; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Di Filippo M; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Pettorossi VE; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Tozzi A; Department of Medicine and Surgery, University of Perugia, 06156 Perugia, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 23; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Estradiol*/pharmacology
Estradiol*/metabolism
Long-Term Potentiation*
Rats ; Animals ; Amyloid beta-Peptides/metabolism ; Memantine/pharmacology ; Hippocampus/metabolism ; Glutamates/metabolism
Czasopismo naukowe
Tytuł:
Memantine treatment does not affect compulsive behavior or frontostriatal connectivity in an adolescent rat model for quinpirole-induced compulsive checking behavior.
Autorzy:
Straathof M; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. .
Blezer ELA; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
Smeele CE; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
van Heijningen C; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
van der Toorn A; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
Buitelaar JK; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.; Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands.
Glennon JC; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.; Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin 4, Ireland.
Otte WM; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.; Department of Pediatric Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Dijkhuizen RM; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht & Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. .
Pokaż więcej
Corporate Authors:
TACTICS Consortium
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2022 Aug; Vol. 239 (8), pp. 2457-2470. Date of Electronic Publication: 2022 Apr 14.
Typ publikacji:
Journal Article
MeSH Terms:
Memantine*/pharmacology
Obsessive-Compulsive Disorder*/chemically induced
Obsessive-Compulsive Disorder*/drug therapy
Animals ; Compulsive Behavior/chemically induced ; Compulsive Behavior/drug therapy ; Disease Models, Animal ; Dopamine Agonists/pharmacology ; Quinpirole/pharmacology ; Rats ; Rats, Long-Evans ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł:
Does memantine show chemopreventive effect against mice 4T1 breast tumor model?
Autorzy:
Albayrak G; Department of Medical Biology, Faculty of Medicine, Ufuk University, Ankara, Turkey.
Bali EB; Department of Medical Services and Techniques, Vocational School of Health Services, Gazi University, Ankara, Turkey.
Korkmaz FD; Department of Medical Biology, Faculty of Medicine, Giresun University, Ankara, Turkey.
Bağrıaçık EÜ; Department of Immunology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2022 Jun; Vol. 52 (3), pp. 841-847. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
Memantine*/pharmacology
Interleukin-6*
Animals ; Female ; Mice ; Mice, Inbred BALB C ; Disease Models, Animal ; Injections, Intraperitoneal
Czasopismo naukowe
Tytuł:
Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.
Autorzy:
Andrzejewski K; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.
Jampolska M; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.
Mojzych I; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.; Department of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.
Conde SV; Faculdade de Ciencias Médicas, NOVA Medical School, Universidade NOVA de Lisboa, 1169-056 Lisbon, Portugal.
Kaczyńska K; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 May 26; Vol. 23 (11). Date of Electronic Publication: 2022 May 26.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Alzheimer Disease*/genetics
Memantine*/pharmacology
Memantine*/therapeutic use
Acetylcholinesterase ; Animals ; Disease Models, Animal ; Humans ; Hypercapnia/drug therapy ; Hypoxia/drug therapy ; Mice ; Mice, Transgenic ; Quality of Life ; Respiration ; Rivastigmine/pharmacology ; Rivastigmine/therapeutic use
Czasopismo naukowe
Tytuł:
Memantine administration prevented chorea movement in Huntington's disease: a case report.
Autorzy:
Saigoh K; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan. .; Department of Life Science, Faculty of Science, and Engineering, Kindai University, 377-2, Ohno-Higashi, Osakasayama, Osaka, 589-8511, Japan. .; Department of Clinical Genetics, Kindai University Hospital, Osakasayama, Japan. .
Hirano M; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Mitsui Y; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Oda I; Department of Clinical Genetics, Kindai University Hospital, Osakasayama, Japan.
Ikegawa A; Department of Clinical Genetics, Kindai University Hospital, Osakasayama, Japan.
Samukawa M; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Yoshikawa K; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Yamagishi Y; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Kusunoki S; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Nagai Y; Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Oct 16; Vol. 17 (1), pp. 431. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Huntington Disease*/complications
Huntington Disease*/drug therapy
Huntington Disease*/diagnosis
Chorea*/drug therapy
Chorea*/genetics
Alzheimer Disease*
Dyskinesias*/etiology
Dyskinesias*/complications
Male ; Female ; Humans ; Aged ; Memantine/therapeutic use ; Iofetamine
Czasopismo naukowe
Tytuł:
Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
Autorzy:
Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, 02114, USA.
Stahl SM; Department of Psychiatry, VAMC (SD), University of California, San Diego, La Jolla, CA, 92093, USA.; Neuroscience Education Institute, Carlsbad, CA, 92008, USA.
De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Bettini E; In Vitro Pharmacology Department, Aptuit, an Evotec Company, 37135, Verona, Italy.
Comai S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.; Department of Biomedical Sciences, University of Padua, 35122, Padua, Italy.; Department of Psychiatry, McGill University, Montreal, QC, H3A 1A1, Canada.
Alimonti A; Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland.; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), 6500, Bellinzona, Switzerland.; Università della Svizzera Italiana, 6900, Lugano, Switzerland.; Veneto Institute of Molecular Medicine, 35129, Padua, Italy.; Department of Medicine-DIMED, University of Padua, 35122, Padua, Italy.
Bifari F; Department of Medical Biotechnology and Translational Medicine, University of Milan, 20122, Milan, Italy.
Pani L; Relmada Therapeutics, Coral Gables, FL, 33134, USA.; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami, Miami, FL, 33146, USA.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41121, Modena, Italy.
Folli F; Department of Health Sciences, University of Milan, 20122, Milan, Italy.
Guidetti C; Child and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Gesù Pediatric Hospital, 00165, Rome, Italy.
Furlan A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Sgrignani J; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
Locatelli P; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
Cavalli A; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.
O'Gorman C; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Traversa S; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Inturrisi CE; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Pappagallo M; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Manfredi PL; Relmada Therapeutics, Coral Gables, FL, 33134, USA. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Oct; Vol. 273 (7), pp. 1463-1476. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Alzheimer Disease*/drug therapy
Humans ; Excitatory Amino Acid Antagonists/pharmacology ; Memantine/pharmacology ; Memantine/therapeutic use ; Antidepressive Agents/pharmacology ; Antidepressive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies.
Autorzy:
Buccellato FR; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
D'Anca M; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Tartaglia GM; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Del Fabbro M; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Scarpini E; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Galimberti D; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 09; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*/metabolism
United States ; Humans ; Aged ; Acetylcholinesterase ; Amyloid beta-Peptides/metabolism ; Memantine/therapeutic use ; Memantine/pharmacology ; Antibodies, Monoclonal/therapeutic use
Czasopismo naukowe
Tytuł:
Memantine Improves the Disturbed Glutamine and γ-Amino Butyric Acid Homeostasis in the Brain of Rats Subjected to Experimental Autoimmune Encephalomyelitis.
Autorzy:
Dąbrowska-Bouta B; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Strużyńska L; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Sidoryk-Węgrzynowicz M; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Sulkowski G; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 24; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalomyelitis, Autoimmune, Experimental*/drug therapy
Antifibrinolytic Agents*
Animals ; Rats ; Rats, Inbred Lew ; Glutamine ; Memantine/pharmacology ; Memantine/therapeutic use ; Brain ; Glutamic Acid ; gamma-Aminobutyric Acid ; Amino Acids ; Homeostasis
Czasopismo naukowe
Tytuł:
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact.
Autorzy:
Olazarán J; Unidad de Trastornos de La Memoria, HM Hospitales and Servicio de Neurología, HGU Gregorio Marañón, Madrid, Spain. .
Carnero-Pardo C; FIDYAN Neurocenter, Granada, Spain.
Fortea J; Memory Unit, Department of Neurology, Hospital de La Santa Creu I Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Sánchez-Juan P; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Fundación CIEN (Centro de Investigación de Enfermedades Neurológicas), Madrid, Spain.
García-Ribas G; Hospital Universitario Ramón y Cajal, Madrid, Spain.
Viñuela F; Instituto Neurológico Andaluz, Hospital Victoria Eugenia, Seville y Unidad de Deterioro Cognitivo, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Martínez-Lage P; Fundación Cita Alzheimer, Donostia-San Sebastian, Gipuzkoa, Spain.
Boada M; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Aug 03; Vol. 15 (1), pp. 130. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/drug therapy
Alzheimer Disease*/epidemiology
COVID-19*/epidemiology
Humans ; Male ; Female ; Donepezil/therapeutic use ; Rivastigmine/therapeutic use ; Memantine/therapeutic use ; Cholinesterase Inhibitors/therapeutic use ; Retrospective Studies ; Pandemics ; Prevalence ; Piperidines/therapeutic use ; Phenylcarbamates/therapeutic use ; Indans/therapeutic use ; Galantamine/therapeutic use
Czasopismo naukowe
Tytuł:
Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.
Autorzy:
Özsoy Ş; Department of Physiology, Faculty of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkiye.
Çakir Z; Department of Oral and Dental Health, Faculty of Health Services Vocational School, Tokat Gaziosmanpaşa University, Tokat, Turkiye.
Akçay E; Department of Pathology, Faculty of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkiye.
Gevrek F; Department of Histology, Faculty of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkiye.
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2023 Aug; Vol. 53 (4), pp. 894-901. Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/chemically induced
Alzheimer Disease*/drug therapy
Neurodegenerative Diseases*
Rats ; Male ; Animals ; Memantine/adverse effects ; Streptozocin/adverse effects ; Hippocampus ; Disease Models, Animal ; Maze Learning
Czasopismo naukowe
Tytuł:
Pharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus.
Autorzy:
Kerkeni H; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Brügger D; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Mantokoudis G; Department of Otorhinolaryngology, Head and Neck Surgery, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Abegg M; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Zee DS; Department of Neurology, Ophthalmology, Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Department of Neuroscience, Division of Neuro-Visual and Vestibular Disorders, Johns Hopkins Hospital, Baltimore, MD, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Jul 03; Vol. 23, pp. e935148. Date of Electronic Publication: 2022 Jul 03.
Typ publikacji:
Case Reports; Journal Article; Observational Study
MeSH Terms:
Memantine*/therapeutic use
Nystagmus, Pathologic*/drug therapy
Nystagmus, Pathologic*/etiology
Eye Movements ; Female ; Gabapentin/therapeutic use ; Humans ; Middle Aged ; Vision Disorders ; Visual Acuity
Czasopismo naukowe
Tytuł:
Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
Autorzy:
Yu SP; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, 30322, USA. .; Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, 30033, USA. .
Jiang MQ; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, 30033, USA.
Shim SS; Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, 30033, USA.
Pourkhodadad S; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, 30033, USA.
Wei L; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, 30322, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2023 Jul 03; Vol. 18 (1), pp. 43. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Alzheimer Disease*/metabolism
Ischemic Stroke*/drug therapy
Stroke*
Animals ; Receptors, N-Methyl-D-Aspartate/metabolism ; Memantine/pharmacology ; Memantine/therapeutic use
Czasopismo naukowe
Tytuł:
A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer's disease patients.
Autorzy:
Yaghmaei E; Schmid College of Science and Technology, Chapman University, Orange, CA, United States of America.
Pierce A; Schmid College of Science and Technology, Chapman University, Orange, CA, United States of America.
Lu H; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Patel YM; Schmid College of Science and Technology, Chapman University, Orange, CA, United States of America.
Ehwerhemuepha L; Children's Hospital of Orange County (CHOC), Orange, CA, United States of America.
Rezaie A; Schmid College of Science and Technology, Chapman University, Orange, CA, United States of America.
Sajjadi SA; School of Medicine, University of California, Irvine, Irvine, CA, United States of America.
Rakovski C; Schmid College of Science and Technology, Chapman University, Orange, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 14; Vol. 18 (9), pp. e0291362. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Humans ; Donepezil/therapeutic use ; Memantine/therapeutic use ; Hospitals ; Emergency Service, Hospital
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies